SEK 12.45
(0.4%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 38.7 Million EUR | -6.31% |
2022 | 41.31 Million EUR | 27.99% |
2021 | 32.27 Million EUR | 170.12% |
2020 | 11.94 Million EUR | 556.21% |
2019 | 1.82 Million EUR | -10.05% |
2018 | 2.02 Million EUR | 7.23% |
2017 | 1.88 Million EUR | -5.76% |
2016 | 2 Million EUR | -12.52% |
2015 | 2.28 Million EUR | 78.77% |
2014 | 1.28 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 38.47 Million EUR | 0.31% |
2024 Q1 | 38.36 Million EUR | -0.89% |
2023 Q3 | 40.68 Million EUR | 1.69% |
2023 FY | 38.7 Million EUR | -6.31% |
2023 Q1 | 41.36 Million EUR | 0.13% |
2023 Q4 | 38.7 Million EUR | -4.86% |
2023 Q2 | 40 Million EUR | -3.29% |
2022 Q3 | 42.34 Million EUR | -4.88% |
2022 Q1 | 39 Million EUR | 20.85% |
2022 FY | 41.31 Million EUR | 27.99% |
2022 Q4 | 41.31 Million EUR | -2.45% |
2022 Q2 | 44.51 Million EUR | 14.12% |
2021 Q1 | 12.32 Million EUR | 3.12% |
2021 FY | 32.27 Million EUR | 170.12% |
2021 Q3 | 27.4 Million EUR | 122.17% |
2021 Q4 | 32.27 Million EUR | 17.79% |
2021 Q2 | 12.33 Million EUR | 0.1% |
2020 Q1 | - EUR | 0.0% |
2020 FY | 11.94 Million EUR | 556.21% |
2020 Q4 | 11.94 Million EUR | 0.0% |
2019 FY | 1.82 Million EUR | -10.05% |
2018 FY | 2.02 Million EUR | 7.23% |
2017 FY | 1.88 Million EUR | -5.76% |
2016 FY | 2 Million EUR | -12.52% |
2015 FY | 2.28 Million EUR | 78.77% |
2014 FY | 1.28 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aino Health AB (publ) | 13.51 Million SEK | -186.403% |
Bonzun AB (publ) | 46.75 Million SEK | 17.213% |
Kontigo Care AB (publ) | 49.77 Million SEK | 22.233% |
Medhelp Care Aktiebolag (publ) | 63.75 Million SEK | 39.291% |
RaySearch Laboratories AB (publ) | 1.95 Billion SEK | 98.018% |
Surgical Science Sweden AB (publ) | 4.7 Billion SEK | 99.177% |